• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Low risk of malignancies with thiopurines in an Indian cohort of patients with Inflammatory bowel disease.

作者信息

Singh Arshdeep, Midha Vandana, Sood Ajit

机构信息

Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, 141 001, India.

Department of Internal Medicine, Dayanand Medical College and Hospital, Ludhiana, 141 001, India.

出版信息

Indian J Gastroenterol. 2025 Jun;44(3):390-391. doi: 10.1007/s12664-024-01615-0.

DOI:10.1007/s12664-024-01615-0
PMID:38874867
Abstract
摘要

相似文献

1
Low risk of malignancies with thiopurines in an Indian cohort of patients with Inflammatory bowel disease.印度炎症性肠病患者队列中使用硫唑嘌呤发生恶性肿瘤的风险较低。
Indian J Gastroenterol. 2025 Jun;44(3):390-391. doi: 10.1007/s12664-024-01615-0.
2
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.接受硫嘌呤类药物或抗TNFα抗体治疗的炎症性肠病患者发生恶性肿瘤的风险。
Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):735-44. doi: 10.1002/pds.3621. Epub 2014 Apr 30.
3
Risk of malignancies in patients with inflammatory bowel disease who used thiopurines as compared with other indications: a territory-wide study.与其他适应症患者相比，使用硫唑嘌呤的炎症性肠病患者发生恶性肿瘤的风险：一项全地区性研究。
Therap Adv Gastroenterol. 2020 Nov 18;13:1756284820967275. doi: 10.1177/1756284820967275. eCollection 2020.
4
Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.炎症性肠病相关的硫嘌呤类药物相关性恶性肿瘤：西班牙格拉纳达的本地经验。
World J Gastroenterol. 2013 Aug 14;19(30):4877-86. doi: 10.3748/wjg.v19.i30.4877.
5
The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study.低剂量硫鸟嘌呤在炎症性肠病患者中的药物生存率：一项回顾性观察研究。
Therap Adv Gastroenterol. 2024 Feb 20;17:17562848241228064. doi: 10.1177/17562848241228064. eCollection 2024.
6
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.接受硫嘌呤类药物治疗炎性肠病患者的淋巴增殖性疾病：一项前瞻性观察队列研究。
Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7.
7
Thiopurines and non-melanoma skin cancer: partners in crime in inflammatory bowel diseases.硫嘌呤类药物与非黑素瘤皮肤癌：炎症性肠病的共犯。
Br Med Bull. 2020 Dec 15;136(1):107-117. doi: 10.1093/bmb/ldaa033.
8
Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study.炎症性肠病患者硫嘌呤类药物与别嘌醇联合治疗的结局：一项丹麦全国队列研究。
United European Gastroenterol J. 2020 Feb;8(1):68-76. doi: 10.1177/2050640619868387. Epub 2019 Aug 3.
9
Thiopurines and the Risk of Cancer in Patients With Inflammatory Bowel Disease and Reference Individuals Without Inflammatory Bowel Disease: A Danish Nationwide Cohort Study (1996-2018).硫唑嘌呤与炎症性肠病患者及无炎症性肠病对照个体的癌症风险：一项丹麦全国队列研究（1996 - 2018年）
Clin Gastroenterol Hepatol. 2025 May;23(6):1030-1038. doi: 10.1016/j.cgh.2024.08.006. Epub 2024 Aug 28.
10
Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease.硫唑嘌呤和肿瘤坏死因子拮抗剂对炎症性肠病患者原发性硬化性胆管炎结局的影响。
Aliment Pharmacol Ther. 2022 Sep;56(5):857-868. doi: 10.1111/apt.17123. Epub 2022 Jul 4.

引用本文的文献

1
Revisiting thiopurines and therapeutic drug monitoring in IBD: Insights and implications in the Indian context.重新审视硫唑嘌呤及炎症性肠病的治疗药物监测：印度背景下的见解与启示
Indian J Gastroenterol. 2025 Aug 29. doi: 10.1007/s12664-025-01864-7.

本文引用的文献

1
Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care. uphill battle：硫唑嘌呤治疗在全球炎症性肠病治疗中的创新。
Indian J Gastroenterol. 2024 Feb;43(1):36-47. doi: 10.1007/s12664-024-01529-x. Epub 2024 Feb 21.
2
Use of thiopurines in inflammatory bowel disease: an update.硫唑嘌呤在炎症性肠病中的应用：最新进展
Intest Res. 2022 Jan;20(1):11-30. doi: 10.5217/ir.2020.00155. Epub 2021 Apr 15.
3
Risk of malignancies in patients with inflammatory bowel disease who used thiopurines as compared with other indications: a territory-wide study.
与其他适应症患者相比，使用硫唑嘌呤的炎症性肠病患者发生恶性肿瘤的风险：一项全地区性研究。
Therap Adv Gastroenterol. 2020 Nov 18;13:1756284820967275. doi: 10.1177/1756284820967275. eCollection 2020.
4
Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases.预测、预防和管理炎症性肠病患者的治疗相关并发症
Clin Gastroenterol Hepatol. 2020 May;18(6):1324-1335.e2. doi: 10.1016/j.cgh.2020.02.009. Epub 2020 Feb 12.
5
Primary Epstein-Barr virus infection.原发性 EBV 感染。
J Clin Virol. 2018 May;102:84-92. doi: 10.1016/j.jcv.2018.03.001. Epub 2018 Mar 5.